5AM Venture Management, LLC Long-Term Concentrated

CIK: 0001799883 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $401,433 (100.0% shares, 0.0% debt)

Holdings (24)

ELVN ENLIVEN THERAPEUTICS INC 29.5%
Value ($000) $118,347 Shares 5,798,475 Est. Cost $20.34 Unrealized -0.6%
TRDA ENTRADA THERAPEUTICS INC 16.6%
Value ($000) $66,743 Shares 4,408,379 Est. Cost $17.12 Unrealized
IRON DISC MEDICINE INC 5.4%
Value ($000) $21,687 Shares 488,442 Est. Cost $49.79 Unrealized -28.7%
RALLYBIO CORP 5.1%
Value ($000) $20,550 Shares 3,630,724 Est. Cost $17.58 Unrealized
VOR BIOPHARMA INC 4.9%
Value ($000) $19,658 Shares 6,361,723 Est. Cost $43.10 Unrealized
MLTX MOONLAKE IMMUNOTHERAPEUTICS 4.5%
Value ($000) $18,232 Shares 357,486 Est. Cost $25.81 Unrealized +4.3%
CRNX CRINETICS PHARMACEUTICALS IN 3.9%
Value ($000) $15,538 Shares 862,286 Est. Cost $19.04 Unrealized +4.7%
ZNTL ZENTALIS PHARMACEUTICALS INC 3.4%
Value ($000) $13,823 Shares 490,000 Est. Cost $23.99 Unrealized 0.0%
SCPHARMACEUTICALS INC 3.0%
Value ($000) $12,235 Shares 1,200,647 Est. Cost $5.92 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 2.6%
Value ($000) $10,527 Shares 310,270 Est. Cost $33.70 Unrealized 0.0%
VKTX VIKING THERAPEUTICS INC 2.4%
Value ($000) $9,483 Shares 585,000 Est. Cost $14.60 Unrealized +43.5%
COGT COGENT BIOSCIENCES INC 2.3%
Value ($000) $9,359 Shares 790,440 Est. Cost $6.91 Unrealized +66.0%
PHVS PHARVARIS N V 2.2%
Value ($000) $8,896 Shares 587,600 Est. Cost $18.63 Unrealized -48.3%
ARVN ARVINAS INC 2.0%
Value ($000) $7,942 Shares 320,000 Est. Cost $29.28 Unrealized -12.2%
RNAM AVIDITY BIOSCIENCES INC 1.8%
Value ($000) $7,381 Shares 665,555 Est. Cost $18.92 Unrealized -33.7%
ANAB ANAPTYSBIO INC 1.8%
Value ($000) $7,276 Shares 357,733 Est. Cost $28.24 Unrealized -28.2%
MIRATI THERAPEUTICS INC 1.7%
Value ($000) $6,955 Shares 192,500 Est. Cost $36.13 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 1.7%
Value ($000) $6,661 Shares 280,000 Est. Cost $17.98 Unrealized +42.7%
SPRUCE BIOSCIENCES INC 1.3%
Value ($000) $5,083 Shares 2,364,000 Est. Cost $2.21 Unrealized
MERSANA THERAPEUTICS INC 1.1%
Value ($000) $4,293 Shares 1,305,000 Est. Cost $4.03 Unrealized
HOMOLOGY MEDICINES INC 1.0%
Value ($000) $4,014 Shares 4,535,919 Est. Cost $20.70 Unrealized
IMPEL PHARMACEUTICALS INC 0.9%
Value ($000) $3,664 Shares 2,884,791 Est. Cost $8.85 Unrealized
GHRS GH RESEARCH PLC 0.4%
Value ($000) $1,804 Shares 152,022 Est. Cost $10.26 Unrealized 0.0%
CIDARA THERAPEUTICS INC 0.3%
Value ($000) $1,282 Shares 1,134,511 Est. Cost $3.84 Unrealized